However, since we and others observe an independent effect of LCN2 on appetite when administered to the CNS of healthy mice15, and if LCN2 blockade also mitigates tumorigenesis, these observations only bolster the notion that targeting LCN2 during pancreatic cancer could prove beneficial through multiple therapeutic means. Here, LCN2 is linked to pancreatic neoplasm.